News

EQT to sell Karo Healthcare to KKR, terms undisclosed
EQT and KKR (KKR) announced that EQT VIII fund has agreed to sell Karo Healthcare to KKR. The acquisition marks the next chapter for Karo, as ...
KKR price target lowered to $150 from $165 at Citizens JMP
Citizens JMP analyst Devin Ryan lowered the firm’s price target on KKR (KKR) to $150 from $165 and keeps an Outperform rating on the shares.